Adial Pharmaceuticals (ADIL) Payables (2017 - 2026)
Adial Pharmaceuticals' Payables was $2.62 million in Q2 2026, up 291.0% from $671,118 a year earlier and up 357.5% from the prior quarter.
Powered by 
Analysis
Adial Pharmaceuticals (ADIL) Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Payables at Adial Pharmaceuticals came in at $655,000, up 161.9% from FY2024.
- Payables shows a five-year compound annual growth rate of 0.2% (FY2020 to FY2025).
- In earlier years, Payables was $250,130 in FY2024 (+142.1%), $103,325 in FY2023 (-62.6%), $276,410 in FY2022 (-3.4%) and $286,192 in FY2021 (-55.9%).
- The Q2 2026 figure marks the highest quarterly Payables in data going back to Q4 2017.
- Compared with a year earlier, Payables has increased for nine straight quarters, with growth averaging 159.7% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q2 2026 (growth of 291.0%); the worst was Q2 2023 (a decline of 81.9%).
- Per Business Quant data, ADIL's Payables in the three quarters before Q2 2026 was $573,567 (Q1 2026), $655,000 (Q4 2025) and $556,284 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.46 Bn | 1,101.04 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 614.45 Bn | 532.98 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.76 Bn | 476.87 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 367.67 Bn | 322.05 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.09 Bn | 262.08 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.81 Bn | 235.50 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.49 Bn | 191.89 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.25 Bn | 165.45 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.18 Bn | 116.83 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Adial Pharmaceuticals | 19.39 Mn | -24.39 Mn | - | 2.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.62 Mn |
| Mar 31, 2026 | 573,567.00 |
| Dec 31, 2025 | 655,000.00 |
| Sep 30, 2025 | 556,284.00 |
| Jun 30, 2025 | 671,118.00 |
| Mar 31, 2025 | 532,430.00 |
| Dec 31, 2024 | 250,130.00 |
| Sep 30, 2024 | 318,118.00 |
| Jun 30, 2024 | 316,726.00 |
| Mar 31, 2024 | 177,468.00 |
| Dec 31, 2023 | 103,325.00 |
| Sep 30, 2023 | 81,925.00 |
| Jun 30, 2023 | 111,702.00 |
| Mar 31, 2023 | 530,141.00 |
| Dec 31, 2022 | 276,410.00 |
| Sep 30, 2022 | 278,200.00 |
| Jun 30, 2022 | 617,778.00 |
| Mar 31, 2022 | 415,086.00 |
| Dec 31, 2021 | 286,192.00 |
| Sep 30, 2021 | 185,187.00 |
API Access
Adial Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ADIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ADIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ADIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();